Skip to main content
Top
Published in: Journal of General Internal Medicine 4/2009

01-04-2009 | Editorial

Medically Unexplained Physical Symptoms

Authors: Jeffrey L. Jackson, MD, MPH, Susan George, MD, Sherri Hinchey, MD

Published in: Journal of General Internal Medicine | Issue 4/2009

Login to get access

Excerpt

Physical symptoms are the most common reason patients seek medical attention. Among those presenting with symptoms, up to a third remain unexplained, even after thorough investigation1. Fortunately, most patients with unexplained symptoms improve and prospective studies show that the rate of resolution is similar to patients with explained symptoms2. However, there is a subgroup with persistent unexplained symptoms. There are numerous colorful descriptions of such patients, such as “difficult,” “frustrating” or “heartsink,”3 with heartsink referring to the feeling clinicians have when they see a particular name on their schedule. While many patients have unexplained symptoms, the term “medically unexplained symptoms” has taken on a life of its own. Studies investigating the characteristics of “difficult” patient encounters reveal that both patient and physician characteristics play a role.4 These patients have multiple, persistent, unexplained physical symptoms. Their symptoms are more severe; they have poor functioning and tend not to improve over time. There is some evidence that less experienced clinicians and those with poorer psychosocial orientation experience a greater percentage of encounters as difficult. Both parties in these encounters emerge unsatisfied and short-term outcomes are poor. …
Literature
1.
go back to reference Kroenke K, Mangelsdorff AD. Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. Am J Med. 1989;86(3):262–6.CrossRefPubMed Kroenke K, Mangelsdorff AD. Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. Am J Med. 1989;86(3):262–6.CrossRefPubMed
2.
go back to reference Jackson JL, Passamonti M. The outcomes among patients presenting in primary care with a physical symptom at 5 years. J Gen Intern Med. 2005;20(11):1032–37.CrossRefPubMed Jackson JL, Passamonti M. The outcomes among patients presenting in primary care with a physical symptom at 5 years. J Gen Intern Med. 2005;20(11):1032–37.CrossRefPubMed
3.
go back to reference Jewell D. I do not love thee Mr Fell...techniques for dealing with heartsink patients. BMJ. 1988;297:498–9.PubMedCrossRef Jewell D. I do not love thee Mr Fell...techniques for dealing with heartsink patients. BMJ. 1988;297:498–9.PubMedCrossRef
4.
go back to reference Jackson JL, Kroenke K. Difficult patient encounters in the ambulatory clinic: clinical predictors and outcomes. Arch Intern Med. 1999;159:1069–75.CrossRefPubMed Jackson JL, Kroenke K. Difficult patient encounters in the ambulatory clinic: clinical predictors and outcomes. Arch Intern Med. 1999;159:1069–75.CrossRefPubMed
5.
go back to reference Aaron LA, Buchwald D. A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med. 2001;134(9):868–81.PubMed Aaron LA, Buchwald D. A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med. 2001;134(9):868–81.PubMed
6.
go back to reference Petrou M, Harris RE, Foerster BR, et al. Proton MR spectroscopy in the evaluation of cerebral metabolism in patients with fibromyalgia: comparison with healthy controls and correlation with symptom severity. Am J Neuroradiol. 2008;29(5):913–8.CrossRefPubMed Petrou M, Harris RE, Foerster BR, et al. Proton MR spectroscopy in the evaluation of cerebral metabolism in patients with fibromyalgia: comparison with healthy controls and correlation with symptom severity. Am J Neuroradiol. 2008;29(5):913–8.CrossRefPubMed
7.
go back to reference Diers M, Koeppe C, Yilmaz P, et al. Pain ratings and somatosensory evoked responses to repetitive intramuscular and intracutaneous stimulation in fibromyalgia syndrome. J Clin Neurophysiol. 2008;25(3):153–60.CrossRefPubMed Diers M, Koeppe C, Yilmaz P, et al. Pain ratings and somatosensory evoked responses to repetitive intramuscular and intracutaneous stimulation in fibromyalgia syndrome. J Clin Neurophysiol. 2008;25(3):153–60.CrossRefPubMed
8.
go back to reference Kroenke K, Spitzer RL, deGruy FV 3rd, et al. Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiatry. 1997;54(4):352–8.PubMed Kroenke K, Spitzer RL, deGruy FV 3rd, et al. Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiatry. 1997;54(4):352–8.PubMed
9.
go back to reference Jackson JL, Kroenke K. Prevalance, impact and prognosis of multisomatoform disorder in primary care: a 5-year follow-up study. Psychosom Med. 2008;70(4):430–4.CrossRefPubMed Jackson JL, Kroenke K. Prevalance, impact and prognosis of multisomatoform disorder in primary care: a 5-year follow-up study. Psychosom Med. 2008;70(4):430–4.CrossRefPubMed
10.
go back to reference Jackson JL, Kroenke K. The effect of unmet expectations among adults presenting with physical symptoms. Ann Intern Med. 2001;134:889–97.PubMed Jackson JL, Kroenke K. The effect of unmet expectations among adults presenting with physical symptoms. Ann Intern Med. 2001;134:889–97.PubMed
11.
go back to reference Salmon P, Ring A, Humphries GM, Davies JC, Dowrick CF. Primary care consultations about medically unexplained symptoms: how do patients indicate what they want? J Gen Intern Med. Salmon P, Ring A, Humphries GM, Davies JC, Dowrick CF. Primary care consultations about medically unexplained symptoms: how do patients indicate what they want? J Gen Intern Med.
12.
go back to reference Peters S, Rogers A, Salmon P, et al. What do patients choose to tell their doctors? Qualitative analysis of potential barriers to reattributing medically unexplained symptoms. J Gen Intern Med. Peters S, Rogers A, Salmon P, et al. What do patients choose to tell their doctors? Qualitative analysis of potential barriers to reattributing medically unexplained symptoms. J Gen Intern Med.
13.
go back to reference Leiblum SR, Schnall E, Seehuus M, DeMaria A. To BATHE or not to BATHE: patient satisfaction with visits to their family physician. Fam Med. 2008;40(6):407–11.PubMed Leiblum SR, Schnall E, Seehuus M, DeMaria A. To BATHE or not to BATHE: patient satisfaction with visits to their family physician. Fam Med. 2008;40(6):407–11.PubMed
14.
go back to reference Smith RC, Lyles JS, Gardiner JC, et al. Primary care clinicians treat patients with medically unexplained symptoms: a randomized controlled trial. J Gen Intern Med. 2006;21(7):671–7.CrossRefPubMed Smith RC, Lyles JS, Gardiner JC, et al. Primary care clinicians treat patients with medically unexplained symptoms: a randomized controlled trial. J Gen Intern Med. 2006;21(7):671–7.CrossRefPubMed
15.
go back to reference Tofferi JK, O’Malley PG, Jackson JL. Treatment of fibromyalgia with cyclobenzaprine: A metaanalysis. Arthritis Care Res. 2004;51(1):9–13.CrossRef Tofferi JK, O’Malley PG, Jackson JL. Treatment of fibromyalgia with cyclobenzaprine: A metaanalysis. Arthritis Care Res. 2004;51(1):9–13.CrossRef
16.
go back to reference O’Malley PG, Jackson JL, Balden E, Tomkins G, Santoro J, Kroenke K. Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Practice. 1999;48:980–99. O’Malley PG, Jackson JL, Balden E, Tomkins G, Santoro J, Kroenke K. Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Practice. 1999;48:980–99.
17.
go back to reference Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med. 2007;69(9):881–8.CrossRefPubMed Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med. 2007;69(9):881–8.CrossRefPubMed
Metadata
Title
Medically Unexplained Physical Symptoms
Authors
Jeffrey L. Jackson, MD, MPH
Susan George, MD
Sherri Hinchey, MD
Publication date
01-04-2009
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 4/2009
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-009-0932-x

Other articles of this Issue 4/2009

Journal of General Internal Medicine 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.